Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children

Table 4 Concentrations of FGF19,VEGF and sklotho protein in children with type 1 diabetes according to the degree of metabolic control

Variable	FGF19	VEGF	sklotho
Variable	Mean(SD) (min, max)	Mean(SD) (min, max)	Mean(SD) (min, max)
G1:HbA1c < 7.5% (N = 19)	233.71(21.37)(189.53,260.83)	207.58(40.32)(146.57,271.27)	2723.73(820.03)(1232.75,3802.56)
G2:HbA1c 7.5−11.0% (N = 26)	227.33(18.33)(193.14,266.25)	231.61(32.64)(180.06,298.98)	2559.68(770.88)(1232.75,3923.97)
G3:HbA1c > 11.0% (N = 21)	210.01(15.01)(186.82,247.29)	247.08(60.39)(154.65,376.34)	2062.37(667.53)(1070.87,3418.10)
P	0.045	0.039	0.018
P(post-hoc analysis)	G1 vs. G3 p = 0.014	G1 vs. G3 p = 0.049	G1 vs. G3 p = 0.007 G2 vs. G3 p = 0.028

ISSN: 1471-2431